Stock RNAZ TRANSCODE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart TransCode Therapeutics, Inc.

Equities

RNAZ

US89357L3033

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-28 pm EDT 		5-day change 1st Jan Change
1.005 USD -0.50% Intraday chart for TransCode Therapeutics, Inc. +3.73% -84.75%
May. 29 TransCode Therapeutics, Inc. Reports Positive Data from First-In-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138 CI
May. 15 TransCode Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
TRANSCODE THERAPEUTICS, INC. Stock TransCode Therapeutics, Inc.
 6.66M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 113B
ARGENX SE Stock argenx SE
 26.02B -
BIONTECH SE Stock BioNTech SE
 19.39B -
GENMAB A/S Stock Genmab A/S
 15.91B
  1. Stock Market
  2. Equities
  3. RNAZ Stock
  4. Charts TransCode Therapeutics, Inc.
  5. Sector Chart